Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 13, 2021

SELL
$13.43 - $19.16 $1.65 Million - $2.36 Million
-123,000 Closed
0 $0
Q1 2021

May 14, 2021

SELL
$15.82 - $22.11 $227,507 - $317,963
-14,381 Reduced 10.47%
123,000 $2.02 Million
Q4 2020

Feb 02, 2021

BUY
$7.91 - $22.95 $3,899 - $11,314
493 Added 0.36%
137,381 $2.84 Million
Q3 2020

Nov 05, 2020

BUY
$7.36 - $9.87 $172,334 - $231,106
23,415 Added 20.63%
136,888 $1.04 Million
Q2 2020

Aug 12, 2020

BUY
$4.67 - $8.95 $391,686 - $750,663
83,873 Added 283.35%
113,473 $945,000
Q4 2019

Jan 27, 2020

BUY
$2.57 - $4.73 $76,072 - $140,008
29,600 New
29,600 $117,000

Others Institutions Holding OCUL

About OCULAR THERAPEUTIX, INC


  • Ticker OCUL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,966,896
  • Market Cap $627M
  • Description
  • Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...
More about OCUL
Track This Portfolio

Track California Public Employees Retirement System Portfolio

Follow California Public Employees Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California Public Employees Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California Public Employees Retirement System with notifications on news.